Lithium 1000 mcg (lithium orotate) – cognitive support in an ultra-low dose
Dietary supplements (other substances) in vegetarian capsules - non-GMO, gluten-free

Lithium is a trace mineral that forms part of the body's biological regulatory network in very small quantities. This formulation delivers 1000 mcg (1 mg) of elemental lithium per capsule from lithium orotate in a simple, gluten- and soy-free vegetarian capsule. The text is designed neutrally and in line with Norwegian and European regulations for dietary supplements, without medical claims.

Summary
Lithium 1000 mcg is a low-dose dietary supplement for adults. The product is described neutrally, without health claims, as there are currently no EFSA-approved health claims for lithium. The formulation is clean, easy to dose and suitable for daily use after assessment by healthcare personnel.

Health benefits
There are no EFSA-approved health claims for lithium. This section is therefore without claims and only describes the product's nature, content and use in a neutral way.

Technical details and specifications
Product type: Food supplements (other substances)
Form: Vegetarian capsules
Features: Gluten-free, non-GMO, vegetarian
Source: Lithium orotate (expressed as elemental lithium per capsule)
Number of capsules: 100

Label information
Statutory designation: Dietary supplements with lithium (other substances)
Ingredients (in descending order, by function): Microcrystalline cellulose (filler), vegetable cellulose (capsule), lithium orotate (active ingredient, source of elemental lithium).
Recommended use/daily dose: Adults take 1 capsule daily, preferably at the same time of day, or as recommended by healthcare professionals. The recommended daily dose should not be exceeded.
Amount per daily dose: Lithium (as lithium orotate) 1000 mcg (1 mg). Reference intake (RI): Not established.
Allergens: No known allergens added. Free of gluten and soy.
Serving size and number of servings: 1 capsule. 100 capsules per box (100 days consumption at 1 capsule daily).
Storage: Store in a dry and dark place, tightly closed and out of the reach of children. Do not use if outer seal is broken.
Responsible business: Manufacturer: Life Extension, USA. Importer/distributor (EEA): Uno Vita AS, Norway. The batch number and "best before" date are indicated on the packaging.
Regulatory notice (Norway/EU): Lithium is classified as "other substance" in dietary supplements. There are currently no EFSA-approved health claims for lithium; information is therefore given neutrally and without claims.

Reservation
Allowed to be used by adults. The recommended daily dose should not be exceeded. The effect may vary from person to person. Dietary supplements should not replace a varied and balanced diet or a healthy lifestyle. Keep out of the reach of children. Uno Vita AS does not claim that the products we market can cure disease.

Disclaimer
Uno Vita increasingly uses artificial intelligence for analyses, summaries and design of articles. We do not accept responsibility for possible errors in texts, articles or descriptions due to human or computer technology (AI) errors, inaccuracies or missing information in scientific and medical studies. The information is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Freedom of expression and right to information
Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like, in line with the UN Universal Declaration of Human Rights (Article 19), the International Covenant on Civil and Political Rights (Article 19), the Constitution § 100 and the US First Amendment.

Scientific references

1. Molecular actions and therapeutic potential of lithium in nervous system disorders. Pharmacology & Therapeutics (2010).

2. Lithium induces autophagy by inhibiting inositol monophosphatase. PNAS (2005).

3. Glycogen synthase kinase-3 inhibition and the treatment of mood disorders. Bipolar Disorders (2004).

4. Potential mechanisms of action of lithium in mood disorders: a comprehensive review. CNS Drugs (2013).

5. Neuroprotective effects of lithium: an update. CNS Neuroscience & Therapeutics (2014).

6. Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Review of Molecular Medicine (2004).

7. Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres. Translational Psychiatry (2013).

8. Lithium treatment and risk of dementia. Journal of Alzheimer's Disease (2017).

9. Telomere length and mitochondrial DNA copy number in patients treated with lithium. Int J Neuropsychopharmacol (2016).

10. Lithium and autophagy: a possible link to neuroprotection. Int J Mol Sci (2017).

11. The science and practice of lithium therapy. Aust N Z J Psychiatry (2012).

12. The role of lithium in neuroplasticity and neuroprotection. Molecular Psychiatry (2009).

13. Regulation of signal transduction pathways by lithium. Brain Research Bulletin (1999).

14. Disease-modifying properties of long-term lithium treatment in amnestic MCI: randomized trial. British J Psychiatry (2011).

15. Lithium as a neuroprotective strategy in Alzheimer's disease: translational evidence. J Alzheimer's Disease (2019).

16. Optimal frequency and dose of lithium: balancing efficacy and tolerability. CNS Drugs (2011).

17. Low-dose lithium and cognitive function in ageing: evidence review. Neurosci Biobehav Rev (2013).

18. Lithium's effects on glucose metabolism in the brain: implications for cognition. Brain Research (2000).

19. Lithium and neurodegenerative disease: targeting GSK-3. Expert Opin Ther Targets (2004).

20. The glamorous GSK-3: a pivotal enzyme in various biological processes. Trends Biochem Sci (2004).

21. Lithium 1000 mcg - product sheet and manufacturer information. Life Extension (2025)